Strategies for Success: Optimizing Antiretroviral Therapy in Heavily Treatment–Experienced Patients

Download All
In this online program led by expert faculty, learn about evaluating causes of antiretroviral treatment failure, selecting new regimens to regain virologic suppression, and integrating recent advances in antiretroviral management into the care of heavily treatment–experienced patients, including both those with detectable viremia and those with virologic suppression on suboptimal older regimens. View the foundational module and case-based vlogs and have your questions answered by faculty during the live webinars. Download the slides and read the companion ClinicalThought commentaries.
Melissa Badowski, PharmD, MPH, FIDSA, FCCP, BCIDP, BCPS, AAHIVP
Josep M. Llibre, MD, PhD
Paul E. Sax, MD


Here’s my take on how to optimize the switching of antiretroviral therapy in patients with virologic suppression and a history of antiretroviral resistance.

Paul E. Sax, MD Released: October 17, 2022

Here’s why I think using newer novel agents earlier could affect virologic suppression and mortality for people with multidrug-resistant HIV.

Josep M. Llibre, MD, PhD Released: November 17, 2022

Lenacapavir is from a new drug class and may be a promising component of antiretroviral therapy if adherence can be ensured.

Melissa Badowski, PharmD, MPH, FIDSA, FCCP, BCIDP, BCPS, AAHIVP Released: January 5, 2023

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Cookie Settings